Restoring Safeguards for Dangerous Abortion Drugs Act
About This Bill
Committee
Latest Action · September 30, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
H.R. 5646, the Restoring Safeguards for Dangerous Abortion Drugs Act, would reverse recent FDA regulatory changes to mifepristone, a medication used for medication abortion. Within 90 days of enactment, the bill requires the Secretary of Health and Human Services to withdraw the current safety requirements for mifepristone and reinstate the stricter risk management rules that were in place in June 2011, preventing any future modifications to those earlier standards. The legislation also bans the importation of mifepristone into the United States by any person, including through mail delivery. Additionally, it creates a federal civil liability provision allowing individuals to sue telehealth providers, pharmacies, and other entities that import or transport mifepristone in violation of federal law, with the ability to recover compensatory damages, punitive damages, and attorney's fees—a private right of action that takes effect 90 days after the bill's enactment. This bill would significantly restrict access to medication abortion across the country.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.